Drug Approval | July 02, 2024
Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
Imfinzi also recommended for patients with mismatch repair deficient disease
Imfinzi also recommended for patients with mismatch repair deficient disease
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Signs MoUs with Shri Krishna Ayush University and Dabur India
Subscribe To Our Newsletter & Stay Updated
